Division of Gastroenterology and Hepatology, Lynda K and David M Underwood Center for Digestive Disorders, Houston Methodist Hospital, Houston, Texas.
Semin Neurol. 2023 Aug;43(4):562-571. doi: 10.1055/s-0043-1771457. Epub 2023 Aug 14.
Constipation is one of the most common gastrointestinal features of Parkinson's disease (PD), occurring in over 50% of all PD patients during the course of their disease. Furthermore, constipation is now recognized as an important, prodromal symptom and may predate the onset of the classical motor symptoms by decades. Thereafter, the prevalence and severity of constipation in PD tend to parallel the course of both motor and nonmotor phenomena such as cognitive decline and depression. Difficult defecation (obstructed defecation, dyssynergia) is the primary pathophysiology underlying constipation and likely reflects involvement by the PD process of one or more of the many skeletal muscle groups that are involved in effecting defecation. Management of constipation in PD may be complicated by several patient factors including dysphagia, cognitive impairment, depression, and weak sphincter tone. While the armamentarium available to those who treat constipation, in general, has expanded considerably in recent years, the evidence supporting any therapy in the management of this symptom in PD has remained slim.
便秘是帕金森病(PD)最常见的胃肠道特征之一,超过 50%的 PD 患者在疾病过程中会出现便秘。此外,便秘现在被认为是一个重要的前驱症状,可能在经典运动症状出现前几十年就已经出现。此后,PD 患者便秘的患病率和严重程度往往与运动和非运动现象(如认知能力下降和抑郁)的病程平行。排便困难(梗阻性排便、协同失调)是便秘的主要病理生理学基础,可能反映了 PD 过程中涉及到一个或多个参与排便的骨骼肌群。PD 患者的便秘管理可能因多种患者因素而变得复杂,包括吞咽困难、认知障碍、抑郁和括约肌张力减弱。尽管近年来治疗便秘的方法有了很大的扩展,但支持任何治疗方法的证据仍然很少。